Back to search
ISS Stage I Plasma Cell Myeloma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which ISS Stage I Plasma Cell Myeloma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which ISS Stage I Plasma Cell Myeloma trials you may qualify forThis phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (da…
This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing s…
Multiple myeloma (MM) is a malignant disease of the BM characterized by clonal expansion of plasma cells. Current guidelines recommend that newly diagnosed tran…
This partially randomized phase I/II trial studies the side effects and best dose of elotuzumab and to see how well it works when given together with lenalidomi…
This pilot clinical trial studies the side effects of pembrolizumab and radiation therapy in treating patients with stage I-III multiple myeloma that has come b…